Inventor · disambiguated record
Shuai Chen
Also filed as: CHEN SHUAI
14 granted patents·9 pending applications·7 citations·filing 2003–2024
85Inventor score
Files withARBUTUS BIOPHARMA CORP7WISTAR INST4CYTOCARES SHANGHAI INC2PETRA PHARMA CORP2ARBUTUS BIOPHARMA INC1
Top patents by PatentIndex Score
23 records- 0191US10981867B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2019·Granted Apr 20, 2021·3 cites·13 claims
- 0291US10442763B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2016·Granted Oct 15, 2019·4 cites·5 claims
- 0384US2024246909A1EBNA1 Inhibitors and Methods Using SameWISTAR INST·Filed 2024·Application pending·0 cites
- 0475US11912659B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 0561US9854798B2Water-soluble granule formulation of 2,4-D salt and preparation method thereofSHANDONG WEIFANG RAINBOW CHEM·Filed 2013·Granted Jan 2, 2018·0 cites·15 claims
- 0661US2024182460A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 0759US11013726B2Substituted pyridinone-containing trycyclic compounds, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2020·Granted May 25, 2021·0 cites·27 claims
- 0858US12122756B2Biflavone compound against I-type herpes simplex virus, and preparation method therefor and use thereofSICHUAN ACAD OF SCIENCES OF TRADITIONAL CHINESE MEDICINE·Filed 2022·Granted Oct 22, 2024·0 cites·11 claims
- 0958US2024018115A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 1056US10821103B2Substituted pyridinone-containing trycyclic compounds, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2017·Granted Nov 3, 2020·0 cites·58 claims
- 1156US9408384B2Water-soluble granule formulation of 2,4-D salt and preparation method thereofSUN GUOQING·Filed 2012·Granted Aug 9, 2016·0 cites·13 claims
- 1255US12128084B2Use of PAYCS in regulation of intestinal flora, metabolites, and brain neurotransmittersSERICULTURE AND AGRI FOOD RES INSTITUTE GUANGDONG ACADEMY OF AGRICULTURAL SCIENCES·Filed 2023·Granted Oct 29, 2024·0 cites·6 claims
- 1352US2024376123A1Kras g12d inhibitors and uses thereofSUZHOU ZANRONG PHARMA LTD·Filed 2022·Application pending·0 cites
- 1451US2023083973A1Substituted cyclopropyl-2,2'-bipyrimidinyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 1551US2023019280A1Substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 1649US2015118357A1Quarg-like cheese and manufacturing method thereofGUO BENHENG·Filed 2012·Application pending·0 cites
- 1748US7374899B2Sucrose-6-phosphate phosphatase as target for herbicidesBASF AG·Filed 2003·Granted May 20, 2008·0 cites·8 claims
- 1848US2022125771A1Substituted polycyclic carboxylic acids, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 1945US11702427B2Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2019·Granted Jul 18, 2023·0 cites·41 claims
- 2044US11505551B2Methods for preparing substituted pyridinone-containing tricyclic compoundsARBUTUS BIOPHARMA CORP·Filed 2019·Granted Nov 22, 2022·0 cites·31 claims
- 2144US2021251991A1Substituted 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 2235US12234479B2Bifunctional molecule and use thereofCYTOCARES SHANGHAI INC·Filed 2017·Granted Feb 25, 2025·0 cites·10 claims
- 2330US11535666B2Trifunctional molecule and application thereofCYTOCARES SHANGHAI INC·Filed 2017·Granted Dec 27, 2022·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Shuai Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →